Key takeaways
Both the Wegovy injection and pill contain semaglutide as their active ingredient, but the injection is administered once weekly, and the pill is taken daily.
The Wegovy injection is slightly more effective for weight loss, producing an average 14.9% weight loss compared to 13.6% with the pill in clinical trials.
The Wegovy pill is generally less expensive and easier to store than the injectable form, which typically requires refrigeration.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
Both the Wegovy injection and pill contain semaglutide as their active ingredient, but the injection is administered once weekly, and the pill is taken daily.
The Wegovy injection is slightly more effective for weight loss, producing an average 14.9% weight loss compared to 13.6% with the pill in clinical trials.
The Wegovy pill is generally less expensive and easier to store than the injectable form, which typically requires refrigeration.
The Wegovy pill is an oral form of injectable Wegovy (semaglutide), but that’s not the only difference between the two. Read on as we compare the Wegovy pill vs. injection and break down nine key differences between the two.
Wegovy pill vs. injection: at a glance
The Wegovy pill and the injection work similarly, as they contain the same active ingredient: semaglutide. Specifically, these GLP-1 medications work by:
Slowing down digestion, so you feel full sooner
Stimulating the release of insulin, while limiting glucagon, after you eat
Boosting satiety (fullness) signals in the brain, reducing appetite and cravings
Together, these effects can produce weight loss and better blood sugar control, making Wegovy effective for treating a variety of conditions, from obesity to reducing heart disease risk.
Here’s a quick look at the main differences when comparing the Wegovy injection vs. pill.
| Wegovy pill | Wegovy injection |
|---|---|---|
Active ingredient | Semaglutide | Semaglutide |
FDA-approved indications | Weight loss in adults with obesity or overweight
Reduced cardiovascular risk in adults with heart disease and obesity or overweight | Weight loss in people ages 12+ with obesity
Weight loss in adults with overweight
Reduced cardiovascular risk in adults with heart disease and obesity or overweight
Treatment of fatty liver disease (MASH) in adults |
Form | Oral tablet | Subcutaneous (under-the-skin) injection |
Frequency | Daily | Weekly |
Administration | Daily tablet
Swallowed whole in the morning at least 30 minutes before eating, drinking, or taking other medications | Weekly subcutaneous (under-the-skin) injection in the thigh, abdomen, or upper arm
Taken at any time of day with or without food |
Dosage strengths | 1.5 mg, 4 mg, 9 mg, 25 mg | 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg |
Effectiveness | Average 13.6% weight loss in 64 weeks | Average 14.9% weight loss in 68 weeks |
Side effects | Nausea, diarrhea, vomiting, constipation, stomach pain or upset, dizziness, headache, fatigue, heartburn, gas | Similar to Wegovy pill, plus injection site reactions (e.g. redness, irritation) |
Storage | Room temperature (68°F–77°F) in original bottle, away from moisture and direct sunlight | Refrigerated (36°F–46°F) in original carton (if needed, may be stored at room temperature of 46°F–86°F for up to 28 days) |
Cost (without insurance) | $1,349.02 (list price)
$149–$299/month, depending on dose (cash price) | $1,349.02 (list price)
$199–$349/month, depending on dose (cash price) |
Wegovy pill vs. injection: how they’re taken and absorbed
Two of the main differences between the Wegovy pill and injection are how they’re taken and absorbed by the body.
Administration
The Wegovy pill is taken once daily in the morning on an empty stomach, at least 30 minutes before eating, drinking, or taking other medications. You can take it with up to 4 ounces of water.
The Wegovy injection comes in a single-use, prefilled injection pen that’s injected subcutaneously (under-the-skin) of your abdomen, thigh, or upper arm once a week, on the same day each week. You can take it any time of day, with or without food, drink, or other medications. Just be sure to rotate injection sites each week to prevent irritation.
Absorption
Compared to the Wegovy injection, the Wegovy pill has a much lower bioavailability (i.e. how much of the active ingredient is available in your bloodstream). That’s why the pill comes in higher doses than the injection.
The Wegovy pill has a low bioavailability of 1%–2%. This is because semaglutide is poorly absorbed by the gastrointestinal (GI) tract when taken orally. To account for this, the Wegovy pill:
Comes in higher dosage strengths than the injection: 1.5 mg–25 mg vs. 0.25 mg–2.4 mg, respectively
Contains SNAC technology to increase absorption in the gut
Oral Wegovy reaches its peak concentration in your bloodstream within one hour.
Meanwhile, the Wegovy injection has a much higher bioavailability of 89% because semaglutide is absorbed more efficiently when injected under the skin. It reaches its peak concentration in your bloodstream within 1–3 days.
Wegovy pill vs. injection: doses and dosage schedules
The Wegovy pill and injection come in different dosage strengths and follow different dosing schedules (daily vs. weekly).
The Wegovy pill is taken daily and comes in four dosage strengths: 1.5 mg, 4 mg, 9 mg, and 25 mg. The recommended maintenance dosage is 25 mg daily.
The Wegovy injection is administered weekly and comes in five dosage strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg. The recommended maintenance dosage is 2.4 mg weekly, but some people may tolerate the 1.7 mg dosage better and stick with that.
Both the Wegovy pill and injection follow a gradual titration schedule, during which you start at a low dosage and gradually increase to your maintenance dosage over a period of months. However, it may take longer to reach your maintenance dosage on the Wegovy injection.
Each bottle of the Wegovy pill contains 30 tablets (or 30 daily doses). The dosage is typically increased every 30 days during titration.
Each carton of the Wegovy injection contains four pens (or four weekly doses). The dosage is typically increased every 4 four weeks during titration.
Wegovy pill | Wegovy injection |
|---|---|
Month 1 (Days 1–30): 1.5 mg daily | Month 1 (Weeks 1–4): 0.25 mg weekly |
Month 2 (Days 31–60): 4 mg daily | Month 2 (Weeks 5–8): 0.5 mg weekly |
Month 3 (Days 61–90): 9 mg daily | Month 3 (Weeks 9–12): 1 mg weekly |
Month 4+ (Day 90+): 25 mg daily | Month 4 (Weeks 13–16:) 1.7 mg weekly |
| Month 5+ (Weeks 16–20+): 1.7 mg or 2.4 mg weekly |
Does the Wegovy pill cost as much as the Wegovy injection?
When purchased with cash, the prices of the Wegovy pill vary depending on the dosage strength, with lower doses costing less than higher doses. However, even the highest dose of the Wegovy pill is less expensive than the Wegovy injection.
The Wegovy pill costs $149–$299 per month, depending on the dosage strength, when purchased using self-pay on Ro.
The Wegovy injection costs $199–$349 per month, depending on dosage strength, when purchased using self-pay on Ro. (FYI, the $199 per month is a limited offer for the first month of the 0.25 mg and 0.5 mg doses and is only available through March 31, 2026.)
Both the Wegovy pill and Wegovy injection may cost even less, if your insurance provides coverage for Wegovy. For example, people with insurance coverage for Wegovy may be able to get Wegovy for as low as $25 with the official Wegovy Savings Offer. If you don’t have coverage through your plan, you may be able to save using the self-pay options described above.
People with prescription drug coverage through Medicare, Medicaid, or other federal, state, or government-funded programs are not eligible for the self-pay offer. In those cases, you may have a lower copay through your insurance plan. Or, if you pay cash for your prescriptions, you may be able to save with a Wegovy coupon or prescription discount card.
Which is more effective for weight loss: Wegovy pill or injection?
The Wegovy injection is slightly more effective for weight loss than the Wegovy pill, according to existing research. However, the two forms have not been compared directly (i.e. head-to-head) in clinical trials.
Here’s what the current research shows:
In a clinical trial that lasted 64 weeks, the Wegovy pill produced an average weight loss of 13.6%.
In a clinical trial that lasted 68 weeks, the Wegovy injection produced an average weight loss of 14.9%.
Wegovy pill vs. injection: timing requirements
The Wegovy pill has strict timing requirements, while the Wegovy injection only needs to be taken on the same day each week.
For the Wegovy pill, you must:
Take it first thing in the morning on an empty stomach.
Swallow it whole with up to 4 ounces of water. Do not crush, split, chew, or dissolve the pill.
Wait at least 30 minutes before eating, drinking, or taking other medications.
For the Wegovy injection, you only need to take it on the same day each week. The specific time of day is not important, and you don’t need to worry about when you eat, drink, or take other medications.
Wegovy pill vs. injection: storage
The Wegovy pill should be stored at room temperature in its original bottle. The Wegovy injection should be refrigerated, although it can be stored at room temperature, if needed, for a limited amount of time.
Storage for the Wegovy pill:
The Wegovy pills should be stored in their original bottle at room temperature of 68°F–77°F (20°C–25°C).
They can be temporarily moved at higher (86°F or 30°C) or lower temperatures (59°F or 15°C) if needed.
The pills should be stored in a dry place away from moisture.
Storage for the Wegovy injection:
Ideally, the Wegovy pens should be stored in their original carton in the refrigerator at 36°F–46°F (2°C–8°C).
If needed, they can be stored at room temperature of 46°F–86°F (8°C–30°C) for up to 28 days.
Never freeze Wegovy pens or tablets. Store Wegovy in a dry place away from direct light and extreme temperatures.
Wegovy pill vs. injection: side effects and risks
Since they both contain semaglutide as their active ingredient, the Wegovy pill and injection have similar side effects. The only difference is that the Wegovy injection may also cause injection site reactions (such as redness, irritation, or discomfort).
The most common side effects of Wegovy include:
Nausea
Abdominal pain
Diarrhea
Vomiting
Constipation
While rare, Wegovy can cause serious side effects, including:
Acute pancreatitis
Diabetic retinopathy complications (diabetes-related vision changes)
Hypoglycemia (low blood sugar), especially when used with insulin
Kidney or gallbladder problems
Severe gastrointestinal reactions
Allergic reactions
Increased heart rate
Pulmonary aspiration during general anesthesia or deep sedation
The Wegovy pill and injection, and other medications containing semaglutide, such as Ozempic and Rybelsus, carry a boxed warning for thyroid tumors based on animal studies. It’s unknown if the medication has the same effect in humans, but people with a personal or family history of thyroid cancer should not take any form of oral or injectable semaglutide.
People who are pregnant, breastfeeding, or planning to conceive should also not take Wegovy.
Can you switch between the Wegovy pill and injection?
Yes, you can switch between the Wegovy pill and injection. Some people may tolerate one form of the medication better than the other. Or your insurance coverage or personal preferences may change.
It’s generally recommended to switch once you’re already taking a maintenance dose of the medication (25 mg for the Wegovy pill, 1.7 mg or 2.4 mg for the Wegovy injection).
To switch from the Wegovy pill to the injection, start the injection the day after you stop taking the pill.
If you were handling 25 mg fine, your healthcare provider may start you on 2.4 mg of Wegovy injection.
If the 25 mg pill was giving you trouble, they may start you on 1.7 mg of the injection.
Once you make the switch, you’ll follow a weekly administration schedule. Meaning, you’ll take Wegovy on the same day each week (vs. daily in the morning, as is the case for the pill).
To switch from the Wegovy injection to the pill, start the pill one week after you stop the injection.
Once you make the switch, you’ll likely start taking 25 mg daily.
Always follow your healthcare provider’s guidance when switching between the Wegovy pill and injection.
Which is better for you: Wegovy pill or injection?
The Wegovy pill and injection are both effective, safe medications for weight loss and other conditions. The right choice for you depends on your lifestyle, insurance coverage, and other health conditions.
The Wegovy pill may be better if you:
Have a fear of needles
Like the routine of taking a daily pill
Can wait to eat, drink, or take other medications in the morning
Don’t want to worry about refrigerating your medication
Don’t want to deal with disposing of needles in an FDA-approved sharps container
Pay cash for your prescriptions
The Wegovy injection may be better if you:
Prefer the flexibility of once-weekly dosing, as opposed to daily
Don’t want to wait to eat, drink, or take other medications in the morning
Want larger weight loss results
Have fatty liver disease (MASH)
Have better insurance coverage for the Wegovy injection vs. pill
Bottom line
Deciding between the Wegovy pill vs. injection ultimately depends on your personal preferences, budget, and health goals. Both forms are effective and safe, but they have some key differences.
The Wegovy pill and injection both contain semaglutide as their active ingredient and cause similar side effects.
Research suggests the Wegovy injection produces slightly greater weight loss (14.9%) compared to the pill (13.6%) over a similar time period.
The Wegovy injection offers flexibility with a once-weekly dose at any time of day, whereas the pill must be taken every morning on an empty stomach.
If you are paying out of pocket, the Wegovy pill is the more affordable option, costing $149–$299 per month vs. $199–$349 for the injection.
The pill should be stored at room temperature, making it travel-friendly, while the injection pens generally need to be kept in the refrigerator.
Frequently asked questions (FAQs)
Are Wegovy pills as effective as injections?
Is oral semaglutide the same as Wegovy?
Yes, but not always. Oral semaglutide is available under two brand names: the Wegovy pill, which can be prescribed for weight loss and cardiovascular risk reduction, and Rybelsus, which comes in lower dosage strengths and can be prescribed for type 2 diabetes. Both are oral GLP-1 medications.
Is the Wegovy pill cheaper than the injection?
Yes, the Wegovy pill is often less expensive than the pen when you opt for self-pay or pay cash. On Ro, for example, the Wegovy pill is available for $149–$299 per month while the injection has a cash price of $199–$349 per month. However, both forms of Wegovy have a list price of $ of $1,349.02 per month.
Does oral Wegovy have fewer side effects?
Yes and no. Both oral and injectable Wegovy contain the same active ingredient (semaglutide) and cause similar gastrointestinal side effects such as nausea, vomiting, diarrhea, abdominal pain, and constipation. However, injectable Wegovy may also rarely cause reactions at the injection site, such as rash or irritation.
Do the Wegovy pill and injection have the same approved uses?
The Wegovy pill and injection are both approved for weight loss and reducing cardiovascular risk in people with heart disease and obesity or overweight, alongside diet and exercise. However, the injection has additional approved indications when compared to the pill.
Wegovy pill | Wegovy injection |
|---|---|
Weight loss and weight management in adults with obesity or with overweight and a weight-related health condition
Cardiovascular risk reduction in adults with heart disease and obesity or overweight
| Weight loss and weight management in people 12 years and older with obesity or adults with overweight and a weight-related health condition
Cardiovascular risk reduction in adults with heart disease and obesity or overweight
Treatment of fatty liver disease (MASH) in adults with moderate to advanced liver fibrosis |
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
Ozempic Important Safety Information: Read more about serious warnings and safety info.
References
Kommu, S. & Whitfield, P. (2024). Semaglutide. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK603723/
NovoCare-a. (2026). Price your Wegovy. Retrieved from https://www.novocare.com/patient/medicines/wegovy.html
NovoCare-b. (2026). Start saving on Wegovy. Retrieved from https://www.novocare.com/patient/medicines/wegovy/savings-offer.html
The White House. (2025). Fact Sheet: President Donald J. Trump Announces Major Developments in Bringing Most-Favored-Nation Pricing to American Patients. Retrieved from https://www.whitehouse.gov/fact-sheets/2025/11/fact-sheet-president-donald-j-trump-announces-major-developments-in-bringing-most-favored-nation-pricing-to-american-patients/
U.S. Food and Drug Administration (FDA). (2026). Highlights of Prescribing Information: Wegovy (semaglutide) injection, for subcutaneous use; Wegovy (semaglutide) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s033lbl.pdf
Wharton, S., Lingvay, I., Bogdanski, P., et al. (2025). Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. The New England Journal of Medicine, 393(11), 1077–1087. doi: 10.1056/NEJMoa2500969. Retrieved from https://pubmed.ncbi.nlm.nih.gov/40934115/
Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. doi: 10.1056/nejmoa2032183. Retrieved from https://www.nejm.org/doi/10.1056/NEJMoa2032183














